1x7e: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="1x7e" size="450" color="white" frame="true" align="right" spinBox="true" caption="1x7e, resolution 2.80Å" /> '''CRYSTAL STRUCTURE O...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1x7e.gif|left|200px]]<br />
[[Image:1x7e.gif|left|200px]]<br /><applet load="1x7e" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1x7e" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1x7e, resolution 2.80&Aring;" />
caption="1x7e, resolution 2.80&Aring;" />
'''CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH WAY-244'''<br />
'''CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH WAY-244'''<br />


==Overview==
==Overview==
We present the structure-based optimization of a series of estrogen, receptor-beta (ERbeta) selective ligands. X-ray cocrystal structures of, these ligands complexed to both ERalpha and ERbeta are described. We also, discuss how molecular modeling was used to take advantage of subtle, differences between the two binding cavities in order to optimize, selectivity for ERbeta over ERalpha. Quantum chemical calculations are, utilized to gain insight into the mechanism of selectivity enhancement., Despite only two relatively conservative residue substitutions in the, ligand binding pocket, the most selective compounds have greater than, 100-fold selectivity for ERbeta relative to ERalpha when measured using a, competitive radioligand binding assay.
We present the structure-based optimization of a series of estrogen receptor-beta (ERbeta) selective ligands. X-ray cocrystal structures of these ligands complexed to both ERalpha and ERbeta are described. We also discuss how molecular modeling was used to take advantage of subtle differences between the two binding cavities in order to optimize selectivity for ERbeta over ERalpha. Quantum chemical calculations are utilized to gain insight into the mechanism of selectivity enhancement. Despite only two relatively conservative residue substitutions in the ligand binding pocket, the most selective compounds have greater than 100-fold selectivity for ERbeta relative to ERalpha when measured using a competitive radioligand binding assay.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1X7E is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with 244 as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1X7E OCA].  
1X7E is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=244:'>244</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1X7E OCA].  


==Reference==
==Reference==
Line 18: Line 17:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Akopian, T.]]
[[Category: Akopian, T.]]
[[Category: Alvarez, J.C.]]
[[Category: Alvarez, J C.]]
[[Category: Bapat, A.]]
[[Category: Bapat, A.]]
[[Category: Bhat, R.A.]]
[[Category: Bhat, R A.]]
[[Category: Harris, H.A.]]
[[Category: Harris, H A.]]
[[Category: Hsiao, C.]]
[[Category: Hsiao, C.]]
[[Category: Hum, W.T.]]
[[Category: Hum, W T.]]
[[Category: Malakian, K.]]
[[Category: Malakian, K.]]
[[Category: Malamas, M.S.]]
[[Category: Malamas, M S.]]
[[Category: Manas, E.S.]]
[[Category: Manas, E S.]]
[[Category: Miller, C.P.]]
[[Category: Miller, C P.]]
[[Category: Somers, W.S.]]
[[Category: Somers, W S.]]
[[Category: Stahl, M.L.]]
[[Category: Stahl, M L.]]
[[Category: Unwalla, R.J.]]
[[Category: Unwalla, R J.]]
[[Category: Wolfrom, S.]]
[[Category: Wolfrom, S.]]
[[Category: Xu, Z.B.]]
[[Category: Xu, Z B.]]
[[Category: 244]]
[[Category: 244]]
[[Category: agonist]]
[[Category: agonist]]
Line 44: Line 43:
[[Category: nuclear recept transcription factor]]
[[Category: nuclear recept transcription factor]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:01:42 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:51:44 2008''